🇺🇸 FDA
Pipeline program

NK cells

TMMU-BTC-006

Phase 2 mab active

Quick answer

NK cells for Hepatocellular Carcinoma is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hepatocellular Carcinoma
Phase
Phase 2
Modality
mab
Status
active

Clinical trials